CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increase in genome mapping programs
4.1.2. Increasing regulatory & reimbursement scenario for NGS based diagnostic tests
4.1.3. Technological advancements in NGS (Next Generation Sequencing) platforms
4.1.4. Growth in collaborations & partnerships
4.1.5. Reduction in prices
4.2. Market Restraints & Challenges
4.2.1. Accuracy and standardisation concerns
4.2.2. Ethical & legal limitations
4.2.3. Interpretation of complex data from NGS platforms
4.2.4. End-user budget constraints in developing nations
4.3. Market Opportunities
4.3.1. Rise in investments in R&D and utilisation of cloud computing in NGS for large
scale sequencing projects
4.3.2. Application of NGS in molecular diagnostics & precision medicine
4.3.3. Next-generation sequencing data analysis using Big Data
CHAPTER 5. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET – BY
PRODUCT & SERVICE
5.1. Pre-Sequencing Products & Services
5.1.1. Sample Preparation
5.1.1.1. Quality Control
5.1.1.2. DNA Fragmentation, Size Selection, End Repair, and A-Tailing
5.1.1.3. Library Preparation & Target Enrichment
5.2. Sequencing Services
5.2.1. Exome & Targeted Re-Sequencing and Custom Panels
5.2.2. RNA- Sequencing
5.2.3. Whole-Genome Sequencing & De Novo Sequencing
5.2.4. Others
5.3. NGS Data Analysis, Storage and Management
5.3.1. NGS Data Analysis Services
5.3.2. NGS Storage, Management, and Cloud Computing Solutions
5.3.3. NGS Data Analysis Software & Workbenches
5.4. NGS Consumables, Platforms, and Services for Platforms
5.4.1. NGS Consumables
5.4.2. NGS Platforms
5.4.2.1. Illumina
5.4.2.1.1. Nextseq 500
5.4.2.1.2. Miniseq
5.4.2.1.3. Hiseq Series
5.4.2.1.4. Hiseq X Ten & Hiseq X Five
5.4.2.1.5. Novaseq
5.4.2.1.6. Miseq Series
5.4.2.2. Thermo Fisher Scientific
5.4.2.2.1. Ion PGM
5.4.2.2.2. Ion Proton
5.4.2.2.3. Ion S5 & S5 XL
5.4.2.3. Pacific Biosciences
5.4.2.3.1. Pacbio RS II
5.4.2.3.2. Sequel Systems
5.4.2.4. Others
5.4.3. Services for NGS Platforms
CHAPTER 6. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET – BY
TECHNOLOGY
6.1. Sequencing by Synthesis
6.2. Nanopore Sequencing
6.3. Ion Semiconductor Sequencing
6.4. Single Molecule Real Time Sequencing
6.5. Others
CHAPTER 7. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET – BY
APPLICATION
7.1. Diagnostics
7.1.1. Cancer Diagnostics
7.1.2. Reproductive Health Diagnostics
7.1.3. Infectious Disease Diagnostics
7.1.4. Others
7.2. Agricultural & Animal Research
7.3. Drug Discovery
7.4. Others
CHAPTER 8. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET – BY
END USER
8.1. Academic Institutes & Research Centers
8.2. Pharmaceutical & Biotechnology Companies
8.3. Hospitals & Clinics
8.4. Others
CHAPTER 9. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET - BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL NEXT GENERATION SEQUENCING MARKET COMPANY
PROFILES
10.1. Agilent Technologies Inc.
10.2. Becton, Dickson and Company
10.3. 10x Genomics
10.4. DNASTAR
10.5. F. Hoffmann-La Roche AG
10.6. Illumina Inc.
10.7. Thermo Fisher Scientific
10.8. Eurofins Scientific
10.9. Oxford Nanopore Technologies, Ltd
10.10. QIAGEN N.V.
10.11. Perkinelmer, Inc.
10.12. Pacific Biosciences, Inc.
10.13. Macrogen, Inc.
10.14. Genewiz
10.15. BGI
CHAPTER 11. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET -
COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
